Continuus Pharmaceuticals designs, builds, and runs manufacturing processes for pharmaceutical and generic clients.
CONTINUUS Pharmaceuticals works with pharmaceutical and generic companies under a Build-Own-Operate model. They design, build, and run the manufacturing process directly at the client site. This novel business model provides its clients with an exceptional, ”one-shop solution” for their entire development and manufacturing cycle. CONTINUUS Pharmaceuticals is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT. In addition, the company is currently collaborating with hospital systems and pharmacy chains to establish its own generic business, where high-quality, low-cost drugs will be manufactured in the United States.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 29, 2016 | Grant | $1.25M | 1 | National Science Foundation | — | Detail |
Dec 11, 2014 | Grant | $150K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |